CN110438455A - The preparation method of polylactic acid base Ciprofloxacin antibacterial film - Google Patents
The preparation method of polylactic acid base Ciprofloxacin antibacterial film Download PDFInfo
- Publication number
- CN110438455A CN110438455A CN201810411002.8A CN201810411002A CN110438455A CN 110438455 A CN110438455 A CN 110438455A CN 201810411002 A CN201810411002 A CN 201810411002A CN 110438455 A CN110438455 A CN 110438455A
- Authority
- CN
- China
- Prior art keywords
- ciprofloxacin
- polylactic acid
- antibacterial
- preparation
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title claims abstract description 94
- 229960003405 ciprofloxacin Drugs 0.000 title claims abstract description 47
- 229920000747 poly(lactic acid) Polymers 0.000 title claims abstract description 47
- 239000004626 polylactic acid Substances 0.000 title claims abstract description 47
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000758 substrate Substances 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 6
- 239000010936 titanium Substances 0.000 claims description 8
- 238000000151 deposition Methods 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical group [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 238000000313 electron-beam-induced deposition Methods 0.000 abstract description 11
- 238000005516 engineering process Methods 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 7
- 238000002054 transplantation Methods 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 239000010408 film Substances 0.000 description 42
- 239000002131 composite material Substances 0.000 description 26
- 239000000463 material Substances 0.000 description 19
- 241000191967 Staphylococcus aureus Species 0.000 description 15
- 239000012528 membrane Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 230000008021 deposition Effects 0.000 description 4
- 238000010894 electron beam technology Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000973497 Siphonognathus argyrophanes Species 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005566 electron beam evaporation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000001755 magnetron sputter deposition Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000052 poly(p-xylylene) Polymers 0.000 description 1
- 229920006381 polylactic acid film Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/06—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the coating material
- C23C14/12—Organic material
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
- C23C14/24—Vacuum evaporation
- C23C14/28—Vacuum evaporation by wave energy or particle radiation
- C23C14/30—Vacuum evaporation by wave energy or particle radiation by electron bombardment
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种聚乳酸基环丙沙星抗菌薄膜的制备方法。所述方法将环丙沙星粉末与聚乳酸混合均匀,置于反应腔室,调整靶材与洁净的基底的距离为20~30cm,抽真空,镀膜,设置工作电流在7~9A,工作电压在0.8~1.8kV,采用低功率电子束沉积技术制备得到聚乳酸基环丙沙星抗菌薄膜。本发明制得的抗菌薄膜与基底的结合力强,致密性好,膜厚度可控,具有良好的抗菌性,可以用于人工假体的移植,消除局部炎症反应。
The invention discloses a preparation method of polylactic acid-based ciprofloxacin antibacterial film. In the method, ciprofloxacin powder and polylactic acid are evenly mixed, placed in the reaction chamber, the distance between the target and the clean substrate is adjusted to 20-30 cm, vacuumized, coated, the working current is set at 7-9A, and the working voltage is At 0.8-1.8kV, the antibacterial film of polylactate-based ciprofloxacin was prepared by low-power electron beam deposition technology. The antibacterial film prepared by the invention has strong binding force with the substrate, good compactness, controllable film thickness, good antibacterial property, can be used for artificial prosthesis transplantation, and eliminates local inflammatory reaction.
Description
技术领域technical field
本发明属于抗菌薄膜的制备技术领域,涉及一种采用低功率电子束沉积技术的聚乳酸基环丙沙星抗菌薄膜的制备方法。The invention belongs to the technical field of preparation of antibacterial films, and relates to a preparation method of polylactic acid-based ciprofloxacin antibacterial films using low-power electron beam deposition technology.
背景技术Background technique
聚乳酸(PLA)热稳定性好、生产过程无污染、具有良好的生物相容性和可降解性,还具有一定的抗菌性,应用广泛,如用于包装材料、注塑、生物医药等方面,是一种理想的绿色高分子材料。Polylactic acid (PLA) has good thermal stability, no pollution in the production process, good biocompatibility and degradability, and has certain antibacterial properties. It is widely used, such as packaging materials, injection molding, biomedicine, etc. It is an ideal green polymer material.
环丙沙星具有广泛的抗菌作用,对大肠杆菌、金黄色葡萄球菌、绿脓杆菌等具有良好的抗菌效果。Ciprofloxacin has a wide range of antibacterial effects, and has good antibacterial effects on Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa.
低功率电子束沉积技术的原理是一束电子通过5-10kV的电场后被加速,最后聚集到待蒸发材料的表面,当电子束打到待蒸发材料的表面时,电子会迅速损失自己的能量,将能量传递给待蒸发材料使其熔化并蒸发。电子束蒸发是制备高熔点和高纯度薄膜的主要方法,并且功率调节范围广,使用方便。磁控溅射与电子束沉积技术制备的PLA基复合薄膜相比,磁控溅射镀膜过程中会形成电荷积累,而导致电位升高,当电位升高到一定程度时,会导致辉光放电停止,进而产生靶材“中毒”的现象,这种现象使得等离子体不稳定,使溅射得到的PLA基抗菌薄膜不均匀,且缺陷较多([1]李国斌,等.白炭黑的制备技术研究进展[J].华工科技,2014,22(5):57-60;[2]王鸿博,等.PLA基纳米结构银薄膜的抗茵性能[J].纺织学报,2008,29(6):52-55.)。Nguyen等采用同轴静电纺丝技术制备聚乳酸/壳聚糖复合纳米纤维材料,对大肠杆菌的抗菌实验显示,在最初的12h,聚乳酸/壳聚糖纳米复合纤维材料能完全抑制细菌生长,但之后,细菌开始逐渐生长,抑菌持久性差(李顺江等.聚乳酸基抗菌材料研究进展[J].应用化工,2014,43(5):916-918.)。The principle of low-power electron beam deposition technology is that a beam of electrons is accelerated after passing through an electric field of 5-10kV, and finally gathers on the surface of the material to be evaporated. When the electron beam hits the surface of the material to be evaporated, the electrons will quickly lose their energy. , transfer energy to the material to be evaporated to melt and evaporate. Electron beam evaporation is the main method to prepare thin films with high melting point and high purity, and it has a wide range of power adjustment and is easy to use. Compared with the PLA-based composite film prepared by magnetron sputtering and electron beam deposition technology, charge accumulation will be formed during the magnetron sputtering coating process, which will lead to an increase in potential. When the potential rises to a certain level, it will cause glow discharge. Stop, and then produce the target "poisoning" phenomenon, this phenomenon makes the plasma unstable, so that the PLA-based antibacterial film obtained by sputtering is uneven and has many defects ([1] Li Guobin, et al. Preparation of white carbon black Technology research progress [J]. Huagong Science and Technology, 2014, 22 (5): 57-60; [2] Wang Hongbo, et al. Antibacterial performance of PLA-based nanostructure silver film [J]. Textile Journal, 2008, 29 (6 ):52-55.). Nguyen et al. used coaxial electrospinning technology to prepare polylactic acid/chitosan composite nanofiber materials. Antibacterial experiments against Escherichia coli showed that polylactic acid/chitosan nanocomposite fiber materials could completely inhibit bacterial growth in the first 12 hours. But after that, the bacteria began to grow gradually, and the antibacterial persistence was poor (Li Shunjiang et al. Research progress of polylactic acid-based antibacterial materials [J]. Applied Chemical Industry, 2014,43(5):916-918.).
发明内容Contents of the invention
本发明的目的在于提供一种薄膜与基底的结合力强、致密性好的聚乳酸基环丙沙星抗菌薄膜的制备方法,该方法能够在室温条件下沉积纯度高的高分子薄膜。The object of the present invention is to provide a kind of preparation method of polylactide-based ciprofloxacin antibacterial film with strong binding force between film and substrate and good compactness, and the method can deposit high-purity polymer film at room temperature.
实现本发明目的的技术方案如下:The technical scheme that realizes the object of the present invention is as follows:
聚乳酸基环丙沙星抗菌薄膜的制备方法,具体步骤如下:The preparation method of polylactic acid base ciprofloxacin antibacterial film, concrete steps are as follows:
将环丙沙星粉末与聚乳酸混合均匀,置于反应腔室,调整靶材与洁净的基底的距离为20~30cm,抽真空,镀膜,设置工作电流在7~9A,工作电压在0.8~1.8kV,采用低功率电子束沉积技术制备得到聚乳酸基环丙沙星抗菌薄膜。Mix ciprofloxacin powder and polylactic acid evenly, place in the reaction chamber, adjust the distance between the target and the clean substrate to 20-30cm, vacuumize, coat, set the working current at 7-9A, and the working voltage at 0.8- 1.8kV, polylactate-based ciprofloxacin antibacterial film was prepared by low-power electron beam deposition technology.
优选地,所述的基底选自钛片或硅片。Preferably, the substrate is selected from titanium sheet or silicon sheet.
优选地,所述的聚乳酸与环丙沙星的质量比为1:1。Preferably, the mass ratio of polylactic acid to ciprofloxacin is 1:1.
优选地,所述的抽真空时,真空度达到6×10-3~8×10-3Pa。Preferably, the vacuum degree reaches 6×10 -3 ~ 8×10 -3 Pa during the vacuuming.
与现有的技术相比,本发明具有以下优点:Compared with the prior art, the present invention has the following advantages:
(1)电子束蒸发具有更高的能量密度,可以蒸发高熔点的材料,并且蒸发速度快,得到的薄膜纯度高;(1) Electron beam evaporation has higher energy density, can evaporate materials with high melting point, and the evaporation speed is fast, and the obtained film has high purity;
(2)电子束蒸发粒子的动能大,制得的抗菌薄膜与基底的结合力强,致密性好;(2) The kinetic energy of the electron beam evaporated particles is large, and the antibacterial film prepared has strong bonding force with the substrate and good compactness;
(3)电子束蒸发时,薄膜厚度可以根据自带的膜厚仪在沉积的过程中测量,便于控制成膜厚度;(3) When the electron beam is evaporated, the film thickness can be measured during the deposition process according to the built-in film thickness meter, which is convenient for controlling the film thickness;
(4)制备的薄膜材料具有良好的抗菌性,可以用于人工假体的移植,消除局部炎症反应。(4) The prepared film material has good antibacterial property, can be used for implantation of artificial prosthesis, and eliminates local inflammatory reaction.
附图说明Description of drawings
图1是基底为Ti片时,复合膜(PLA:环丙沙星=1:1)对金黄色葡萄球菌的抗菌效果图;Fig. 1 is when substrate is Ti sheet, composite film (PLA: ciprofloxacin=1:1) is to the antibacterial effect figure of Staphylococcus aureus;
图2是基底为Ti片时,复合膜(PLA:环丙沙星=1:1)对铜绿假单胞菌的抗菌效果图;Fig. 2 is when substrate is Ti sheet, composite film (PLA: ciprofloxacin=1:1) is to the antibacterial effect figure of Pseudomonas aeruginosa;
图3是基底为Si片时,复合膜(PLA:环丙沙星=1:1)对铜绿假单胞菌的抗菌效果图;Fig. 3 is when substrate is Si sheet, composite film (PLA: ciprofloxacin=1:1) is to the antibacterial effect figure of Pseudomonas aeruginosa;
图4分别为纯PLA、纯环丙沙星以及复合膜材料(PLA:环丙沙星=1:1)的红外光谱图;Fig. 4 is respectively the infrared spectrogram of pure PLA, pure ciprofloxacin and composite membrane material (PLA: ciprofloxacin=1:1);
图5是电子束沉积复合膜(PLA:环丙沙星=1:1)24h,48h和72h的缓释抗菌效果图;Fig. 5 is the sustained-release antibacterial effect figure of electron beam deposition composite film (PLA: ciprofloxacin=1:1) 24h, 48h and 72h;
图6是PLA基喷环丙沙星复合膜(PLA:环丙沙星=1:1)对金黄色葡萄球菌的抗菌效果图;Fig. 6 is the antibacterial effect figure of PLA base spraying ciprofloxacin composite film (PLA: ciprofloxacin=1:1) to Staphylococcus aureus;
图7是PLA基喷环丙沙星复合膜(PLA:环丙沙星=1:1)12h和24h的缓释效果图。Fig. 7 is the slow-release effect graph of PLA-based spraying ciprofloxacin composite film (PLA:ciprofloxacin=1:1) for 12h and 24h.
具体实施方式Detailed ways
下面结合实施例和附图对本发明作进一步详述。The present invention will be described in further detail below in conjunction with the embodiments and accompanying drawings.
电子束沉积是利用高能电子束轰击靶材,受轰击的靶材区域会产生化学键的离化,同时其温度也会迅速升高,使得靶材组分蒸发,这样靶材就会被转化为由电子、离子、原子和分子组成的等离子体态,等离子体喷发出来形成余辉沉积在基底上。Electron beam deposition is the use of high-energy electron beams to bombard the target. The ionization of chemical bonds will occur in the bombarded target area, and its temperature will also rise rapidly, causing the target components to evaporate, so that the target will be converted into A plasma state composed of electrons, ions, atoms, and molecules, which is ejected to form an afterglow and deposited on the substrate.
实施例1Example 1
分别取两片切割成1*1cm Ti片和Si片,放入乙醇中进行超声波清洗15min,倒掉乙醇再用去离子水冲洗,重复以上清洗步骤3次,将清洗后装有Ti片和Si片的烧杯用保鲜膜封起来,放入马弗炉中烘干。将烘干后的Ti片和Si片放置于电子束沉积的腔室中,用夹子将基底固定,之后进行PLA基环丙沙星抗菌薄膜的沉积,具体步骤如下:Take two slices and cut them into 1*1cm Ti slices and Si slices, put them into ethanol for ultrasonic cleaning for 15 minutes, pour off the ethanol and rinse with deionized water, repeat the above cleaning steps 3 times, and clean the Ti slices and Si slices The beakers of the slices were sealed with plastic wrap and placed in a muffle furnace for drying. Place the dried Ti sheet and Si sheet in the electron beam deposition chamber, fix the substrate with clips, and then deposit the PLA-based ciprofloxacin antibacterial film. The specific steps are as follows:
清理反应室中的污染物:To clean the reaction chamber of contaminants:
将质量比(PLA:环丙沙星=1:1)的靶材放入电子束沉积的反应室中,用机械泵和分子泵分别抽真空,使真空度达到6×10-3~8×10-3Pa。Put the mass ratio (PLA: ciprofloxacin = 1:1) target into the reaction chamber of electron beam deposition, vacuumize with mechanical pump and molecular pump respectively, so that the vacuum degree reaches 6×10 -3 ~8× 10 -3 Pa.
(1)沉积PLA基复合薄膜(1) Deposition of PLA-based composite films
打开沉积薄膜的电源,将工作电流调节在7~9A,工作电压控制在0.8~1.8kV,当真空度显示在5×10-2~6×10-2Pa时,可通过观察窗看到在靶材和基底之间有等离子态的物质由靶材向基底转移,通过膜厚仪上膜厚的变化可以判断沉积是否完成,当膜厚不再变化时,即可说明沉积结束,此时将电流和电压缓慢归零,等待10min,使真空室的温度降下来后,关闭仪器电源,镀膜完成。Turn on the power supply of the deposited film, adjust the working current to 7-9A, and control the working voltage to 0.8-1.8kV. When the vacuum degree is displayed at 5×10 -2 to 6×10 -2 Pa, it can be seen through the observation window that the The material in the plasma state between the target and the substrate is transferred from the target to the substrate, and whether the deposition is completed can be judged by the change of the film thickness on the film thickness meter. When the film thickness no longer changes, it means that the deposition is over. The current and voltage are slowly returned to zero, wait for 10 minutes, and after the temperature of the vacuum chamber is lowered, turn off the power of the instrument, and the coating is completed.
(2)金黄色葡萄球菌的培养(2) Culture of Staphylococcus aureus
称取酵母浸粉0.5g,蛋白胨1.0g,NaCl 1.0g,用去离子水溶解在烧杯中,滴加少许的NaOH溶液,直至pH值调节至7,然后用玻璃棒引流,将溶液倒入100mL的锥形瓶中,定容,摇匀,取三支洗净的小试管,在每个小试管中用移液枪取5.00mL的溶液,然后把试管口用锡纸封上,再把小试管放入高压蒸汽灭菌锅中灭菌。Weigh 0.5g of yeast extract powder, 1.0g of peptone, and 1.0g of NaCl, dissolve them in a beaker with deionized water, add a little NaOH solution dropwise, until the pH value is adjusted to 7, then drain with a glass rod, and pour the solution into 100mL In the Erlenmeyer flask, constant volume, shake well, take three washed small test tubes, take 5.00mL solution in each small test tube with a pipette gun, then seal the test tube mouth with tin foil, and then put the small test tube Sterilize in a high pressure steam sterilizer.
灭菌完成后,将试管,接种环,打火机放入超净工作台中用紫外灯照射20min,照射完成后开风扇吹2min,之后戴上一次性的橡胶手套,取出金黄色葡萄球菌的菌种,点燃酒精灯,用酒精棉擦拭双手及超净工作台,将接种环放在酒精灯外焰上灼烧,直到烧红为止,接种环杆的部分要边旋转边灼烧,再将装有金黄色葡萄球菌的试管口放在酒精灯上烧,然后将接种环伸入到装有金黄色葡萄球菌的试管中,取适量的菌种接种到液体培养基中,然后再用锡纸包好,用橡皮筋扎紧,重复以上步骤三次,直到3个试管都接种完成,熄灭酒精灯,关闭超净工作台,将接种好的金黄色葡萄球菌放入30℃的摇床中,培养12个小时。After the sterilization is completed, put the test tube, inoculation loop, and lighter into the ultra-clean workbench and irradiate it with an ultraviolet lamp for 20 minutes. After the irradiation is completed, turn on the fan to blow for 2 minutes. Then put on disposable rubber gloves and take out the strain of Staphylococcus aureus. Light the alcohol lamp, wipe your hands and the ultra-clean workbench with alcohol cotton, put the inoculation loop on the outer flame of the alcohol lamp and burn it until it burns red. Burn the test tube mouth of Staphylococcus aureus on an alcohol lamp, then extend the inoculation loop into the test tube containing Staphylococcus aureus, take an appropriate amount of bacteria and inoculate it into the liquid medium, then wrap it in tin foil, and use Tighten the rubber band tightly, repeat the above steps three times until all three test tubes are inoculated, turn off the alcohol lamp, close the ultra-clean workbench, put the inoculated Staphylococcus aureus in a shaker at 30°C, and incubate for 12 hours.
(3)PLA基环丙沙星复合膜抗菌性能的研究(3) Study on antibacterial performance of PLA-based ciprofloxacin composite film
称取酵母浸粉0.5g,蛋白胨1.0g,NaCl 1.0g,琼脂粉1.6g,用去离子水溶解在烧杯中,滴加少许的NaOH溶液,直至pH值调节至7,然后用玻璃棒引流,将溶液倒入100mL的锥形瓶中,定容,摇匀,再用封口膜将锥形瓶口封好,将用报纸包好的培养皿、镊子、移液枪头和液体培养基一同放入高压蒸汽灭菌锅中灭菌。Weigh 0.5g of yeast extract powder, 1.0g of peptone, 1.0g of NaCl, and 1.6g of agar powder, dissolve them in a beaker with deionized water, add a little NaOH solution dropwise until the pH value is adjusted to 7, and then drain with a glass rod, Pour the solution into a 100mL Erlenmeyer flask, constant volume, shake well, then seal the mouth of the Erlenmeyer flask with a parafilm, and put the Petri dish wrapped with newspaper, tweezers, pipette tip and liquid medium together Sterilize in a high pressure steam sterilizer.
灭菌完成后将培养皿、移液枪头、移液枪和打火机放入超净工作台中用紫外灯照射20min,用风扇吹2分钟,从培养的三个金黄色葡萄球菌的试管中选择一个效果最好的倒入锥形瓶中,充分震荡,摇匀;将制得的PLA基环丙沙星复合膜裁制为小正方形或者用打孔器打成圆形,以Si片为基底的裁成小正方形,以Ti片为基底的用打孔器打成圆形,将复合膜材料镀膜的一面朝上,并放置于培养皿的中心位置,用移液枪移取10.0mL的培养基到培养皿中,注意移取过程中尽量避免有气泡,移取过程要迅速,防止培养基凝固。最后接种好的培养基放在30℃的培养箱中培养24h,取出后图片见图1,由图1的抑菌圈可知,PLA基环丙沙星复合膜对金黄色葡萄球菌有良好的抗菌效果。After the sterilization is completed, put the petri dish, pipette tip, pipette gun and lighter into the ultra-clean workbench, irradiate with ultraviolet light for 20 minutes, blow with a fan for 2 minutes, and choose one of the three cultured Staphylococcus aureus test tubes The best effect is poured into the Erlenmeyer flask, fully shaken, and shaken; the prepared PLA-based ciprofloxacin composite film is cut into small squares or rounded with a puncher, and the Si sheet is used as the base. Cut into small squares, and use a puncher to make a circle with the Ti sheet as the base. Put the composite membrane material with the coating side up, and place it in the center of the culture dish, and pipette 10.0mL of the culture dish. Transfer the culture medium to the Petri dish, pay attention to avoid air bubbles as much as possible during the pipetting process, and the pipetting process should be rapid to prevent the medium from solidifying. Finally, the inoculated medium was placed in an incubator at 30°C for 24 hours, and the picture after taking it out was shown in Figure 1. From the antibacterial zone in Figure 1, it can be seen that the PLA-based ciprofloxacin composite film has good antibacterial effect on Staphylococcus aureus Effect.
实施例2Example 2
膜材料为实施例1中的PLA基环丙沙星复合膜材料,将实施例1中的金黄色葡萄球菌换为铜绿假单胞菌,其他步骤与实施例1中相同,PLA基环丙沙星复合膜的抗菌效果见图2和图3,当基底为Si片时,菌种为金黄色葡萄菌时,抗菌环直径为5.2cm,菌种为铜绿假单胞菌时,抗菌环直径为4.6cm,所以PLA基环丙沙星复合膜对金黄色葡萄球菌的抗菌效果更好。The membrane material is the PLA-based ciprofloxacin composite membrane material in Example 1, and the Staphylococcus aureus in Example 1 is replaced by Pseudomonas aeruginosa, and other steps are the same as in Example 1, and the PLA-based ciprofloxacin The antibacterial effect of the star composite film is shown in Figure 2 and Figure 3. When the substrate is Si sheet, when the strain is Staphylococcus aureus, the diameter of the antibacterial ring is 5.2cm, and when the strain is Pseudomonas aeruginosa, the diameter of the antibacterial ring is 4.6cm, so the PLA-based ciprofloxacin composite film has a better antibacterial effect on Staphylococcus aureus.
由图4知,PLA基环丙沙星复合膜在波数为1083.7cm-1和1730.7cm-1处分别对应PLA上1083.8cm-1和1743.3cm-1处的透过率,PLA基环丙沙星复合膜在波数1457.4cm-1和1616.8cm-1处分别对应环丙沙星1453.1cm-1和1618.1cm-1处的透过率,说明PLA基环丙沙星复合膜中确实存在PLA和抗生素环丙沙星。It can be known from Figure 4 that the PLA-based ciprofloxacin composite film corresponds to the transmittance at 1083.8cm -1 and 1743.3cm -1 on the PLA at the wavenumbers of 1083.7cm -1 and 1730.7cm -1 respectively, and the PLA-based ciprofloxacin The star composite film at the wave number of 1457.4cm -1 and 1616.8cm -1 corresponds to the transmittance of ciprofloxacin at 1453.1cm -1 and 1618.1cm -1 respectively, indicating that PLA and ciprofloxacin do exist in the PLA-based ciprofloxacin composite film The antibiotic ciprofloxacin.
对比例1Comparative example 1
取三片PLA基环丙沙星复合薄膜分别浸泡在生理盐水中24h,48h,72h后取出,再做抗菌实验,观察PLA基复合薄膜的缓释效果,由图5可知,浸泡24h,48h,72h后的抑菌圈直径分别为4.0cm,1.5cm和0.7cm。随着浸泡时间的延长,复合膜的抗菌效果变差,抑菌圈变小,但是是有抑菌效果的,说明膜材料中的抗生素一直在释放,72h时仍有释放,所以该膜材料已足以满足移植的需要。Take three PLA-based ciprofloxacin composite films soaked in normal saline for 24h, 48h, and 72h, then take them out, and then do antibacterial experiments to observe the slow-release effect of PLA-based composite films. It can be seen from Figure 5 that after soaking for 24h, 48h After 72 hours, the diameters of the inhibition zone were 4.0cm, 1.5cm and 0.7cm. As the soaking time prolongs, the antibacterial effect of the composite membrane becomes worse, and the inhibition zone becomes smaller, but it has an antibacterial effect, indicating that the antibiotics in the membrane material have been releasing, and there is still release after 72 hours, so the membrane material has been released. Enough to meet the needs of transplantation.
在沉积的PLA薄膜上喷环丙沙星的饱和溶液,环丙沙星的质量与沉积时的使用量相同,该膜材料对金黄色萄球菌的抗菌效果图见图6,由图可知PLA喷环丙沙星的膜材料对金黄葡萄球菌有抗菌效果,但是抗菌环不均匀,原因在于喷涂的过程中存在很多的人为因素,不易控制抗生素的含量各处相同。Spray a saturated solution of ciprofloxacin on the deposited PLA film, the quality of ciprofloxacin is the same as the amount used during deposition, the antibacterial effect of the film material on Staphylococcus aureus is shown in Figure 6, it can be seen from the figure that PLA spray The membrane material of ciprofloxacin has an antibacterial effect on Staphylococcus aureus, but the antibacterial ring is not uniform. The reason is that there are many human factors in the spraying process, and it is difficult to control the content of antibiotics to be the same everywhere.
取两片PLA喷涂环丙沙星的复合膜分别浸泡在生理盐水中12h和24h后取出,再做抗菌实验,观察复合薄膜的缓释效果,由图7可知,浸泡12h后的抑菌圈为0.8cm,浸泡24h后就已经没有抑菌圈了,而用电子束沉积制得的膜材料浸泡72h后仍有抑菌圈,说明在PLA上喷环丙沙星制得的膜材料远远不及电子束蒸发的膜基结合力好。PLA上喷环丙沙星制得的膜材料在生理盐水中浸泡薄膜易脱落,缓释效果差,不能用于临床上的移植。综上所述,采用电子束沉积技术制备的PLA基环丙沙星复合薄膜的结合力高,稳定性好。Take two pieces of composite films sprayed with PLA and ciprofloxacin, soak them in normal saline for 12 hours and 24 hours, take them out, and then do antibacterial experiments to observe the slow-release effect of the composite films. It can be seen from Figure 7 that the bacteriostatic zone after soaking for 12 hours is 0.8cm, there is no antibacterial zone after soaking for 24 hours, but the membrane material prepared by electron beam deposition still has an inhibitory zone after soaking for 72 hours, indicating that the membrane material prepared by spraying ciprofloxacin on PLA is far inferior to E-beam evaporated films have good adhesion to substrates. The membrane material prepared by spraying ciprofloxacin on PLA is easy to fall off when soaked in physiological saline, and the sustained release effect is poor, so it cannot be used for clinical transplantation. In summary, the PLA-based ciprofloxacin composite film prepared by electron beam deposition technology has high binding force and good stability.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810411002.8A CN110438455A (en) | 2018-05-02 | 2018-05-02 | The preparation method of polylactic acid base Ciprofloxacin antibacterial film |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810411002.8A CN110438455A (en) | 2018-05-02 | 2018-05-02 | The preparation method of polylactic acid base Ciprofloxacin antibacterial film |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110438455A true CN110438455A (en) | 2019-11-12 |
Family
ID=68426964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810411002.8A Pending CN110438455A (en) | 2018-05-02 | 2018-05-02 | The preparation method of polylactic acid base Ciprofloxacin antibacterial film |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110438455A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020083273A (en) * | 2001-04-26 | 2002-11-02 | 주식회사 엘지이아이 | Anti-bacteria material sheet for manufacturing cooling pin of heat exchanger and fabrication method thereof |
| US20030219562A1 (en) * | 2002-02-15 | 2003-11-27 | Frantisek Rypacek | Polymer coating for medical devices |
| CN102671239A (en) * | 2012-05-03 | 2012-09-19 | 浙江大学 | Method for preparing broad-spectrum antibacterial effect chitosan nano composite gel coating |
| CN106563175A (en) * | 2016-11-21 | 2017-04-19 | 南京理工大学 | Medical antimicrobial coating and preparation method thereof |
-
2018
- 2018-05-02 CN CN201810411002.8A patent/CN110438455A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020083273A (en) * | 2001-04-26 | 2002-11-02 | 주식회사 엘지이아이 | Anti-bacteria material sheet for manufacturing cooling pin of heat exchanger and fabrication method thereof |
| US20030219562A1 (en) * | 2002-02-15 | 2003-11-27 | Frantisek Rypacek | Polymer coating for medical devices |
| CN102671239A (en) * | 2012-05-03 | 2012-09-19 | 浙江大学 | Method for preparing broad-spectrum antibacterial effect chitosan nano composite gel coating |
| CN106563175A (en) * | 2016-11-21 | 2017-04-19 | 南京理工大学 | Medical antimicrobial coating and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 徐元贞等: "《新全实用药物手册 第3版》", 28 February 2005, 河南科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Joorabloo et al. | Fabrication of heparinized nano ZnO/poly (vinylalcohol)/carboxymethyl cellulose bionanocomposite hydrogels using artificial neural network for wound dressing application | |
| ES2623538T3 (en) | Implantable Medical Devices | |
| CN102886071A (en) | Medicinal silver-loaded metal bioactive coating as well as preparation method and application thereof | |
| Zhang et al. | Fabrication and durable antibacterial properties of 3D porous wet electrospun RCSC/PCL nanofibrous scaffold with silver nanoparticles | |
| CN101745147A (en) | Zinc oxide coating modified in vivo implanted artificial organ and preparation method thereof | |
| CN103242551B (en) | Method for injecting titanium ions to modify surface of polyether-ether-ketone | |
| CN105862001A (en) | TiN-Ag nano composite coating and preparation and application thereof | |
| Liang et al. | Silk fibroin immobilization on poly (ethylene terephthalate) films: comparison of two surface modification methods and their effect on mesenchymal stem cells culture | |
| CN103882377B (en) | Preparation method of antibacterial diamond-like carbon/hydroxyapatite gradient multi-component nano-coating | |
| CN106563175A (en) | Medical antimicrobial coating and preparation method thereof | |
| CN106633161A (en) | Preparation method of sericin-polyvinyl alcohol blended antibacterial film loaded with nano-silver, and product and application of antibacterial film | |
| CN111359014A (en) | Preparation method of polylactic acid-based ciprofloxacin/hydroxyapatite composite coating | |
| CN112342496B (en) | Preparation method of double-layer composite film | |
| CN111317865A (en) | Preparation method of double-layer antibacterial composite film | |
| CN110438455A (en) | The preparation method of polylactic acid base Ciprofloxacin antibacterial film | |
| CN109652769A (en) | A kind of medical embedded material magnesium-silver coating and preparation method thereof | |
| CN107583107A (en) | A kind of tantalum boride biological coating and preparation method and application | |
| CN104046951B (en) | A kind of method preparing praseodymium doped titanium nitride coating on medical titanium alloy surface | |
| CN105132869A (en) | Method for carrying out surface modification on polyether-ether-ketone material and modified polyether-ether-ketone material | |
| Trimukhe et al. | RF pulsed plasma modified composite scaffold for enhanced anti-microbial activity and accelerated wound healing | |
| CN105331946B (en) | A kind of method that zirconium-ion implantation improves medical polyetheretherketonematerials materials bioactivity | |
| CN104120396B (en) | The preparation method of nanometer silver coating modifying artificial ligament | |
| CN116041800A (en) | Hydrogel with antibacterial, anti-inflammatory and antioxidant functions and preparation method and application thereof | |
| CN116288203B (en) | Corrosion-resistant antibacterial biomedical composite coating and preparation method thereof | |
| CN109112474B (en) | Preparation method of molybdenum disulfide biological functional coating based on magnetron sputtering of titanium sheet surface |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191112 |
|
| RJ01 | Rejection of invention patent application after publication |